Since the company’s beginning in 2014, Freenome has had a clear vision – to reinvent disease management through early detection and intervention. And over the past three years, our team has been tackling this long term goal by making cancer screening and diagnostics as accurate and accessible as possible, through a fusion of machine learning, biology and computer science. With this, we hope to change the way we approach healthcare by equipping people with the knowledge and tools to maintain a healthier life, and one day, prevent disease altogether.
We are technologists
We are programmers, machine learning experts and computational biologists developing novel computational methods to create effective tools for screening, diagnosis and treatment of age-associated clinical conditions. Because in the age of genomics, traditionally biological questions are giving way to technological solutions.
We are scientists
We are molecular biologists, chemists, and sequencing experts working together to ensure the highest quality of scientific research. We lay the foundation necessary for next-generation screening and treatment methods with academic and pharma partners.